Redefining Preclinical Research with Patient-First Advanced Technology
CaleoBio’s Patient-Derived Organ-Dish Technology Provides a Reliable, Scalable Platform for Drug Development.
Guiding Treatment with Data, Not Doubt.
Trial-and-error approaches fall short in predicting treatment outcomes. By integrating disease modeling with human-first data, we eliminate uncertainty and accelerate the path to effective therapies.
Pioneering the Advanced Preclinical Models.
Unlike traditional preclinical models with critical gaps in emulating human physiology, our next-generation technology integrates epithelial, immune and mesenchymal cells to replicate human diseases.
Eliminating Uncertainty, Elevating Care.
CaleoBio’s patient-first models equip partners with insights to make informed decisions. By bridging lab discoveries to clinical success, we accelerate advanced therapies, ensuring faster delivery to patients.
Merging Precision Medicine with AI.
By combining CaleoBio’s patient-first Organ-Dish technology with AI-driven scalable platform, we empower researchers to optimize drug discovery and therapeutic advancements.
From Tissue Samples to Breakthroughs
Bridging the Gap between
Preclinical Solutions
and
Clinical Success
Predicting Success. Preventing Failure. Improving Lives.
Together, We can Enhance Success Rates, Accelerate Innovation, and Deliver Life-Changing Treatments to Those who Need Them Most.
Advance Drug Discovery with Us —
Smarter, Scalable Approach
Bring your expertise to the forefront and join us to revolutionize drug discovery by replacing outdated models with advanced, patient-derived solutions.